Home / Pharmaceutical company intelligence
S.J & G. Fazul Ellahie (pvt) limited. logo
Pharmaceutical company intelligence

S.J & G. Fazul Ellahie (pvt) limited.

Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.

Follow price changes 🔒 Company report (Pharma Pro)

Private pharmaceutical manufacturer · Karachi · Pakistan

Long-established Pakistan pharmaceutical manufacturing and marketing company producing multiple dosage forms for domestic and international markets.

Sourced corporate profile Corporate identity fields are source-tracked; portfolio, price and competitor intelligence remains independently calculated by MedInfoBase.
Official website ↗ Official contact ↗
ShareSend this page
Evidence & freshness

What is sourced, and how recent is it?

Public-source corporate details
Latest regulatory-source observation27 Sep 2026Newest linked source record observed by MedInfoBase
Latest portfolio source check22 Sep 2026Latest source-check date across this published portfolio
Latest effective price date20 Aug 2026Newest effective date among published current price records
Corporate profile evidence5 sourcesCorporate source details checked 16 Aug 2026

Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.

Regulatory & corporate identity

Company profile

Public-source corporate details
Legal / official name
S. J. & G. Fazul Ellahie (Pvt.) Ltd.
Company type
Private pharmaceutical manufacturer
Address
17, Maqbool Co-op H. Society, Lal M. Choudhry Road, Karachi, Pakistan
Phone
+92 21 111 754 754
Official contact
Contact page ↗
Corporate source details checked
16 Aug 2026
Corporate profile completeness
100%
Source-linked licence identifiersShown as recorded in linked source rows; not a claim of current validity.
DML 000083 193 linked products · source seen 27 Sep 2026 View source ↗
Corporate profile source ledger Logo Url source ↗ Contact Page Url source ↗ Logo Source Url source ↗ Profile Source Url source ↗
Location intelligence

Company location

Google Maps
Location recorded

A sourced company location is recorded. Use the map link below for directions.

Open in Google Maps ↗
Intelligence snapshot

Portfolio at a glance

Not sales data · published MedInfoBase database view
Rx194public portfolio records represented
REG161unique registrations represented
IDX193indexed MedInfoBase presentations
SRC0additional source-observed presentations
R+1registry-only registrations
VER0registry-verified exact registrations
PKR193current validated price records
G68generic molecules in indexed catalogue
DF7dosage-form groups
TA12therapeutic areas
How to read these counts

RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.

PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.

IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.

Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.

Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.

Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.

Data coverage

How complete is this profile?

Current price coverage99%
public portfolio presentations with a validated current price
Official-source coverage100%
products linked back to a source record
Unit-price parse coverage99%
priced packs safely normalized per unit
Comparable-market coverage90%
products with at least one like-for-like comparator
Therapeutic classification100%
products assigned to a broad therapeutic area
Visual intelligence

Downloadable company intelligence charts

Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.

Shareable intelligence

Therapeutic Portfolio Mix

Shows where the company portfolio is concentrated across broad therapeutic areas.

Therapeutic Portfolio MixS.J & G. Fazul Ellahie (pvt) limited.Share of current product presentations by broad therapeutic areaMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/s-j-g-fazul-ellahie-pvt-limitedGenerated 27 Sep 2026Anti-infectives113 · 59%Gastrointestinal & hepatology21 · 11%CNS & mental health16 · 8%Vitamins, minerals & nutrition15 · 8%Cardiovascular7 · 4%Pain & musculoskeletal7 · 4%Respiratory & allergy5 · 3%Other therapeutic areas9 · 5%Percentages are based on current product presentations in the MedInfoBase company portfolio.

Portfolio distribution, not sales or market-share data.

Shareable intelligence

Dosage Form Portfolio

Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.

Dosage Form PortfolioS.J & G. Fazul Ellahie (pvt) limited.Distribution of current product presentations by normalized dosage formMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/s-j-g-fazul-ellahie-pvt-limitedGenerated 27 Sep 2026193presentationsTablet70 · 36%Injection64 · 33%Capsule20 · 10%Suspension17 · 9%Infusion10 · 5%Syrup9 · 5%Other forms3 · 2%Dosage-form wording is normalized for intelligence display; original source wording remains preserved in product records.

Counts are product presentations, not production or sales volumes.

Shareable intelligence

Equivalent Price Position

Shows whether safely comparable products are below, near or above the peer median unit price.

Equivalent Price PositionS.J & G. Fazul Ellahie (pvt) limited.Current company products compared with like-for-like equivalent medicines using normalized unit pricesMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/s-j-g-fazul-ellahie-pvt-limitedGenerated 27 Sep 2026173comparable productsBelow peer median42 · 24%Near peer median40 · 23%Above peer median91 · 53%Company median price position+6.2%Lowest-price equivalents12Method: same generic + stated strength + dosage form + compatible unit basis; pack prices normalized per unit.

This is price-position intelligence, not sales, demand or market-share data.

Shareable intelligence

Closest Portfolio Competitors

Highlights other manufacturers with the greatest generic overlap with this company portfolio.

Closest Portfolio CompetitorsS.J & G. Fazul Ellahie (pvt) limited.Companies with the largest number of shared generic medicines in the MedInfoBase databaseMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/s-j-g-fazul-ellahie-pvt-limitedGenerated 27 Sep 2026Neutro Pharma (Pvt.) Ltd.,41 shared60% overlapMediate Pharmaceutical Pvt Ltd39 shared57% overlapNabiqasim Industries (Pvt) Ltd.,37 shared54% overlapBosch Pharmaceuticals (Pvt) Ltd.37 shared54% overlapBio-Labs(Pvt) Ltd37 shared54% overlapMacter International Limited35 shared51% overlapPortfolio overlap measures shared generics only; it is not a measure of market share, affiliation or sales competition.

Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.

Portfolio intelligence

Therapeutic areas

Broad portfolio view

High-level clinical areas represented by this company’s current MedInfoBase portfolio.

Anti-infectives113 products · 59%
Gastrointestinal & hepatology21 products · 11%
CNS & mental health16 products · 8%
Vitamins, minerals & nutrition15 products · 8%
Cardiovascular7 products · 4%
Pain & musculoskeletal7 products · 4%
Respiratory & allergy5 products · 3%
Fluids & supportive care3 products · 2%
Pharmacological detail

Drug classes

More specific view

More specific classes derived from the canonical generic and preserved curated classifications.

Third-generation cephalosporins20 products · 10%
Vitamins / minerals / hematinics15 products · 8%
Fluoroquinolone antibacterials15 products · 8%
Antivirals12 products · 6%
Antiemetics11 products · 6%
Antimalarials11 products · 6%
Oxazolidinone antibacterials11 products · 6%
Macrolide antibacterials11 products · 6%
Formulation footprint

Dosage forms

Tablet70 products
Injection64 products
Capsule20 products
Suspension17 products
Infusion10 products
Syrup9 products
Solution3 products
How MedInfoBase classifies the portfolio

MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.

Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales
#1 VifyOmeprazole 10presentations 10 mg, 20 mg, 40 mg · Capsule, Injection #2 NezkilLinezolid 8presentations 100 mg/5 mL, 400 mg, 600 mg · Suspension, Tablet, Infusion #3 CefastCeftriaxone 7presentations 1 g, 2 g, 250 mg, 500 mg · Injection #4 CinofloxCiprofloxacin 7presentations 100 mg/50 mL, 125 mg/5 mL, 200 mg/100 mL, 250 mg · Infusion, Suspension, Injection #5 ZeclarClarithromycin 6presentations 125 mg/5 mL, 250 mg, 250 mg/5 mL, 500 mg · Suspension, Tablet, Injection #6 FenuronIbuprofen 5presentations 200 mg, 400 mg, 400 mg/4 mL, 800 mg/8 mL · Tablet, Injection
Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis
🔒
MedInfoBase Pharma Pro

See where S.J & G. Fazul Ellahie (pvt) limited. is priced against the market

173 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.

Below / near / above medianCompany price positionProduct examplesExcel, PDF & PowerPoint
Unlock with Pharma Pro
How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

Neutro Pharma (Pvt.) Ltd.,209 products · 97 generics 41shared generics Mediate Pharmaceutical Pvt Ltd236 products · 90 generics 39shared generics Nabiqasim Industries (Pvt) Ltd.,363 products · 118 generics 37shared generics

🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock

Regulatory & price activity

Observed database signals

Indexed registration numbers160Distinct registrations among indexed, published, presentation-validated products only
Verified price observations378
Products with a verified price193
Products with multiple price observations185
Source records with multiple versions193
Latest portfolio source check22 Sep 2026
Latest effective price date20 Aug 2026
Latest source observation27 Sep 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Company medicine portfolio

Medicine portfolio

161 unique registration(s) · 193 indexed presentation(s) · 1 registry-only registration(s)

This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.

Reset
BrandGenericStrengthFormPackRegistrationSource-listed priceUnit pricePrice position
Maparix Vancomycin 500 mg Injection Vial 050695 PKR 732.77 PKR 732.77/vial/unit 🔒 Pharma Pro
Maparix Vancomycin 500 mg Injection 25's 050695 PKR 17,586.39 PKR 703.46/vial/unit 🔒 Pharma Pro
Maparix 1gm Vancomycin 1 g Injection Vial 083291 PKR 1,271.85 PKR 1,271.85/vial/unit 🔒 Pharma Pro
Maparix 1gm Vancomycin 1 g Injection 25's 083291 PKR 30,524.53 PKR 1,220.98/vial/unit 🔒 Pharma Pro
Merocon Meropenem 500 mg Injection 25's 048625 PKR 50,247.42 PKR 2,009.90/vial/unit 🔒 Pharma Pro
Merocon Meropenem 500 mg Injection 1's 048625 PKR 2,093.64 PKR 2,093.64/vial/unit 🔒 Pharma Pro
Merocon Meropenem 1 g Injection 25's 048626 PKR 93,407.18 PKR 3,736.29/vial/unit 🔒 Pharma Pro
Merocon Meropenem 1 g Injection 1's 048626 PKR 3,891.97 PKR 3,891.97/vial/unit 🔒 Pharma Pro
Midazole Midazole Metronidazole 500 mg Injection 100ml 023039 PKR 161.08 PKR 1.61/mL 🔒 Pharma Pro
Morphine Morphine 15 mg Injection 100 x 1 ml 027913 PKR 763.51 PKR 7.64/mL 🔒 Pharma Pro
Moxibact Moxibact Moxifloxacin 400 mg Tablet 5's 037420 PKR 994.48 PKR 198.90/tablet 🔒 Pharma Pro
New-Zone Ceftriaxone 250 mg IV injection 1's 083165 PKR 155.85 PKR 155.85/vial/unit 🔒 Pharma Pro
Nezkil Linezolid 400 mg Tablet 14's 034783 PKR 3,492.19 PKR 249.44/tablet 🔒 Pharma Pro
Nezkil Linezolid 400 mg Tablet 12's 034783 PKR 2,993.90 PKR 249.49/tablet 🔒 Pharma Pro
Nezkil Linezolid 600 mg Tablet 14's 035263 PKR 5,224.41 PKR 373.17/tablet 🔒 Pharma Pro
Nezkil Linezolid 600 mg Tablet 12's 035263 PKR 4,480.38 PKR 373.37/tablet 🔒 Pharma Pro
Nezkil Linezolid 400 mg IV infusion 200 ml 048803 PKR 911.49 PKR 4.56/mL 🔒 Pharma Pro
Nezkil Linezolid 600 mg IV infusion 300 ml 048804 PKR 1,256.19 PKR 4.19/mL 🔒 Pharma Pro
Nezkil Linezolid 100 mg/5 mL Dry suspension 60 ml 067037 PKR 732.77 PKR 12.21/mL 🔒 Pharma Pro
Nezkil Linezolid 100 mg/5 mL Dry suspension 120 ml 067037 PKR 1,392.27 PKR 11.60/mL 🔒 Pharma Pro
Nezkil Nezkil Linezolid 400 mg Tablet 10's 034783 PKR 2,494.42 PKR 249.44/tablet 🔒 Pharma Pro
Nezkil Nezkil Linezolid 600 mg Tablet 10's 035263 PKR 3,732.66 PKR 373.27/tablet 🔒 Pharma Pro
Nezkil Nezkil Linezolid 200 mg IV infusion 100 ml 048802 PKR 853.19 PKR 8.53/mL 🔒 Pharma Pro
Novus Sofosbuvir 400 mg Tablet 28's 080794 PKR 11,947.21 PKR 426.69/tablet 🔒 Pharma Pro
Orilan Ribavirin 400 mg Tablet 10's 083292 PKR 184.73 PKR 18.47/tablet 🔒 Pharma Pro
Oxyclor Hydroxychloroquine 200 mg Tablet 30's 085954 PKR 554.19 PKR 18.47/tablet 🔒 Pharma Pro
Oxytocin Oxytocin 10 IU/mL Injection 100 x 1 ml 011050 PKR 280.86 PKR 2.81/mL 🔒 Pharma Pro
Paniv Tenofovir disoproxil 300 mg Tablet 30's 058542 PKR 7,124.62 PKR 237.49/tablet 🔒 Pharma Pro
Phenytal Fosphenytoin sodium 100 mg Injection 2 ml 061470 PKR 302.71 PKR 151.36/mL No comparator
Phenytal Fosphenytoin sodium 750 mg fosphenytoin sodium (equiv. phenytoin sodium 500 mg) Injection 10 ml 061471 PKR 1,513.54 PKR 151.35/mL No comparator
Plasare Paroxetine 20 mg Tablet 20's 034877 PKR 1,480.72 PKR 74.04/tablet 🔒 Pharma Pro
Plasare Paroxetine 20 mg Tablet 10's 034877 PKR 755.75 PKR 75.58/tablet 🔒 Pharma Pro
Plasare Paroxetine 30 mg Tablet 10's 047150 PKR 466.79 PKR 46.68/tablet No comparator
Plasare CR Paroxetine 25 mg Tablet 30's 108515 PKR 1,711.01 PKR 57.03/tablet 🔒 Pharma Pro
Pyrazinamide Pyrazinamide 500 mg Tablet 500's 008950 PKR 2,794.89 PKR 5.59/tablet 🔒 Pharma Pro
Pyrazinamide Pyrazinamide 500 mg Tablet 50's 008950 PKR 279.47 PKR 5.59/tablet 🔒 Pharma Pro
Rexamol Paracetamol 500 mg Tablet 1000's 005083 PKR 510.09 PKR 0.51/tablet 🔒 Pharma Pro
Rexaphenicol Chloramphenicol 125 mg/5 mL Suspension 60ml 002207 PKR 79.40 PKR 1.32/mL 🔒 Pharma Pro
Rilonav Lopinavir + Ritonavir 200 mg + 50 mg Tablet 120's 104373 PKR 11,525.22 PKR 96.04/tablet 🔒 Pharma Pro
Seretron Ondansetron 8 mg/4 mL Injection 4mlx1's 135159 PKR 517.00 PKR 129.25/mL 🔒 Pharma Pro
Setak Escitalopram 10 mg Tablet 14's 037398 PKR 777.98 PKR 55.57/tablet 🔒 Pharma Pro
Setak Escitalopram 5 mg Tablet 14's 047420 PKR 666.85 PKR 47.63/tablet 🔒 Pharma Pro
Setak Escitalopram 5 mg Tablet 10's 047420 PKR 477.90 PKR 47.79/tablet 🔒 Pharma Pro
Setak Escitalopram 20 mg Tablet 14's 047421 PKR 1,000.28 PKR 71.45/tablet 🔒 Pharma Pro
Simatin Simatin Simvastatin 10 mg Tablet 10's 027693 PKR 389.20 PKR 38.92/tablet 🔒 Pharma Pro
Simatin Simatin Simvastatin 20 mg Tablet 10's 027694 PKR 722.76 PKR 72.28/tablet 🔒 Pharma Pro
Tamycin Gentamicin 80 mg Injection 2 x 2ml 011613 PKR 106.83 PKR 26.71/mL 🔒 Pharma Pro
Telkot Telkot Loratadine 5 mg/5 mL Syrup 60ml 026278 PKR 84.34 PKR 1.41/mL 🔒 Pharma Pro
Telkot Telkot Loratadine 10 mg Tablet 10's 026279 PKR 227.16 PKR 22.72/tablet 🔒 Pharma Pro
Traslo Losartan 25 mg Tablet 2 x 10's 028707 PKR 211.90 PKR 10.60/tablet 🔒 Pharma Pro
MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.

Cite this record

Manufacturer record
MedInfoBase. (2026). S.J & G. Fazul Ellahie (pvt) limited — registered product portfolio in Pakistan [Data set]. MedInfoBase. Retrieved September 27, 2026, from https://medinfobase.com/company/s-j-g-fazul-ellahie-pvt-limited/
Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Records change over time. Please cite the access date so readers can locate the version you used.